NEORX CORP
S-3/A, EX-23.1, 2000-11-06
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-3/A, 2000-11-06
Next: JPF SEPARATE ACCOUNT A OF JEFFERSON PILOT FINANCIAL INS CO, S-6/A, 2000-11-06



<PAGE>   1

                                                                    EXHIBIT 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS


The Board of Directors
NeoRx Corporation:

        We consent to the use of our report incorporated herein by reference and
to the reference to our firm under the heading "Experts" in the prospectus.



                                       /s/  KPMG LLP
                                       -----------------------------------
                                       KPMG LLP

Seattle, Washington

November 3, 2000




                                       6


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission